10x Genomics announced a collaboration with the NIH Intramural Center for Alzheimer’s and Related Dementias to build a more comprehensive single cell atlas of the human brain to further neuroscience research. Known for complementing a broad range of NIH-funded research that requires harnessing emerging technologies at scale, NIH CARD will use Chromium Single Cell Multiome to profile the epigenome and whole transcriptome across millions of individual cells from ancestrally diverse brain samples.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TXG:
- Curio Bioscience to ‘vigorously defend’ against 10x Genomics’ allegations
- NanoString downgraded to Neutral from Overweight at JPMorgan
- NanoString downgraded to Neutral from Outperform at Baird
- NanoString downgraded to Market Perform at TD Cowen after 10x Genomics ruling
- NanoString disagrees with jury verdict, will seek to have overturned or amended